Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

Publication: PLoS Medicine

Parkinson CA, Gale D, Piskorz AM, Biggs H, Hodgkin C, Addley H, Freeman S, Moyle P, Sala E, Sayal K, Hosking K,  Gounaris I,  Jimenez-Linan M, Earl HM, Qian W, Rosenfeld N, Brenton JD

20 December 2016

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025